Hosted on MSN
CytomX outlines Q1 2026 CX-2051 data update and 100-patient enrollment milestone as Phase Ib study nears
McCarthy expects a "CX-2051 data update in Q1 of next year" and highlighted that "investing behind a potential first approval will continue to be our top capital allocation priority." The company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results